MV-626

N/A

Report date: 2024/12/18 13:39:48

NME

Base Information

Drug NameMV-626

Drug Alias NameMV-626

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionEctonucleotide Pyrophosphatase/Phosphodiesterase 1 inhibitors

TargetsEctonucleotide Pyrophosphatase/Phosphodiesterase 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMavupharma Inc

China Registration ClassN/A

Active CompaniesMavupharma Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A